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Summary We have utilized the blast cell assay of Buick et al. (1977) to grow and subsequently
cytogenetically analyze cultured colony forming cells (CFUs) from patients with acute and chronic
myelogenous leukaemia (AML, CML). Cytogenetic analysis of CFUs was successful in 30/36 cases (83%), a
success rate similar to direct harvesting techniques. Identical clonal chromosomal abnormalities demonstrated
by direct techniques were also observed in CFUs from AML and CML. Removal of T-precursor cells by E-
rosetting prior to plating did not eliminate growth of karyotypically normal cells. The combination of
morphologic and cytogenetic studies performed clearly established that the assay system supports the growth
of leukaemic progenitors. Although both karyotypically normal and abnormal leukaemic colonies grew in this
assay, growth of leukaemic colonies was much more likely if the plated cells were karyotypically abnormal
(P=0.010). Leukaemic colony growth was also more frequent if the tritiated thymidine labelling index (LI%)
of plated cells was .5% (P=0.018). Leukaemic colonies were most likely (P=0.018) to have been derived
from plated cells with both abnormal karyotype and high LI% (>5%). Cytogenetic analyses from cultured
cells revealed only those karyotypic features found in the uncultured cells (i.e., no additional abnormal
sublines were found). However, in most cases, the greatly enhanced number and quality of mitotic figures
allowed for more detailed banding analysis.
The recent development of in vitro assays for
growth of human leukaemic clonogenic cells has
greatly increased our knowledge of cell renewal
systems (Metcalf, 1977). However, few studies have
analyzed the cytogenetic profile of the clonogenic
cells, to obtain direct confirmation of the neoplastic
nature of the stem/progenitor cell population
(Moore & Metcalf, 1973; Dube et al., 1981;
Lowenberg et al., 1980). Recent evidence suggests
that differences in leukaemic culture assays (direct
or clonogenic) may provide growth advantage to
selected cell populations, thus making a direct
comparison of results from different culture
techniques difficult (Knuutila et al., 1981).
We have investigated the cytogenetic and
cytokinetic characteristics of marrow and blood
cells from AML and CML patients by direct
techniques and compared these properties to those
observed in CFUs grown in the methylcellulose
assay of Buick et al. (1977). Our results strongly
suggest that CFUs grown in this assay are derived
from true leukaemic progenitors and reflect the
inherent biologic nature of a patient's leukaemic
cells (as measured by karyology and tritiated
thymidine [3H]-dT labelling index [LI]).
Additionally, our results suggest this assay provides
a simple and reproducible means of analyzing the
cytogenetic profile of leukaemic CFUs.
Materials and methods
Cytogenetics
Cells were harvested for cytogenetic analysis using a
modification of the technique of Trent & Salmon
(1980). Briefly, CFUs were allowed to grow for 72-
96h in 7.5% CO2. Colcemid (0.05pg/ml) was added
the last 4-12h of culture. Clusters or colonies were
then removed from the plates, washed free of
methylcellulose with fresh medium, and placed into
hypotonic (0.075 MKCl prewarmed to 37°C) for 25
min. Following centrifugation (150 x g, 5 min), the
supernatant was removed and 5ml of fresh cold
fixative (3:1 methanol:glacial acetic acid) was added
with vigorous vortex agitation. Cultures were then
washed twice more with fixative and stored at
-9°C. Air-dried slides were prepared and cells
banded by G- (Sun et al., 1973) or C- (Miller et al.,
1976) banding techniques. Chromosome harvesting
of direct bone marrows was performed utilizing
direct and short term liquid culture techniques
(Morse et al., 1977; Shiloh &.Cohen, 1978).
All chromosome changes listed are "clonal"
alterations according to ISCN (1978) definition.
Leukaemia cell culture
Leukaemic cells were obtained from samples of
bone marrow or peripheral blood and cultivated in
methylcellulose as described by Buick et al. (1977).
In brief, mononuclear cells obtained by Ficoll-
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Hypaque density centrifugation, were rosetted with
neuraminidase treated sheep red blood cells
(ERF-C) to remove rosette-forming T lymphocyte
precursors from precursors of leukaemic blast cells
to be cultured. Two hundred thousand cells/plate
were set up in triplicate for each patient sample.
Following a 1 h exposure to control media, cells
were washed thoroughly and plated in 0.8% (v/v)
methylcellulose in Alpha Medium supplemented
with 10% fetal bovine serum and 20% (v/v) PHA-
stimulated leukocyte conditioned medium (PHA-
LCM) (Buick et al., 1977). Cultures were then
incubated at 37°C in a humidified atmosphere of
5% CO2 with air for 7 days. Plates were examined
for growth and categorized as no growth, minimal
growth (e.g., cell doublings), clusters (<30 cells), or
colonies (>30 cells). Routine morphologic and
histochemical analysis with Wright-Giemsa, Sudan
Black B and chloracetate esterase staining was also
used to confirm the leukaemic nature ofcolonies.
litiated thymidine labelling ofplated leukaemic cells
Bone marrow (1-3ml) was aspirated aseptically into
a syringe containing sodium heparin. One-quarter
volume of 3% dextran was then added to each
sample in order to sediment red cells. The
supernatant plasma (which was contained in the
marrow cells) was transferred to a sterile centrifuge
tube and diluted to 45ml with Hank's Balanced
Salt Solution with 10% fetal bovine serum (HBSS-
FBS) and centrifuged 10 min at 600xg. The cell
button was then resuspended in HBSS-FBS, with
the centrifugation and cell washing procedure
repeated twice. A 2-ml aliquot of the washed cell
suspension was placed in a sterile plastic tissue
culture tube and warmed to 37°C in a waterbath.
Five 4uCi of [3H]-dT (specific activity, 40-60
Ci/mM) was added to the cell suspension. After
1 h of incubation, the suspension was washed free of
the unincorporated [3H]-dT by 2 additional washes
with HBSS-FBS. Following incubation, cell
preparations were free of clumping and had a
viability of >98%. Slides for autoradiography and
microscopic examination were prepared utilizing a
cytocentrifuge. Slides for autoradiography were then
dipped in Kodak NTB-3 emulsion and further
processed using high speed scintillation auto-
radiography (HSARG) (Durie & Salmon, 1975).
Routinely, duplicate slides were exposed for 6h and
24h and without scintillator and compared with
conventional autoradiography ([3H]-dt, 18Ci/mM
exposure, 7 days, 2°C). No significant differences
were found in final labelling indices (Durie &
Salmon, 1975). Readings of slides processed using
the HSARG technique and exposed for 24h were
used in this analysis.
Following developing of slides, each slide was
stained with acid Giemsa stain. Autoradiographs
prepared in this fashion were of high quality with a
background median grain count of <35 grains/100
cells. Cells containing >5 grains over the nucleus
were considered labelled. One thousand cells were
counted in order to determine the LI, which was
expresssed as a percentage. The median grain count
of labelled leukaemic cells measured with this LI
technique was .50 grains/cell nucleus. Statistical
considerations regarding threshold grain counts and
relation to background were as described by
Clarkson et al. (1967).
Patient population
A total of 46 patients had bone marrow and/or
peripheral blood samples referred to our
laboratories for direct cytogenetic analysis and
clonal assay. Of these, 7 had CML in the chronic or
blastic phase, the remaining 39 having AML which
was categorized using the FAB classification
(Gralnick et al., 1977). The patients in this study
ranged in age from 12-74 years. Of 39 AML
patients, 31 were classified as M1 or M2; 6 as M4;
and one each M3 and M6. Eight patients were
previously untreated with the remainder being
evaluated at the time of first or later relapse. Drug
treatment of these patients will be reported
elsewhere (Durie et al., submitted for publication).
Results
We compared the success rate of obtaining
analyzable mitoses from direct marrow cells and
leukaemic CFUs. Forty-one of 46 (91.1%) of direct
marrows and 30/36 (83.3%) methylcellulose cultures
provided sufficient mitoses for cytogenetic analysis.
This difference was not statistically different (n=72,
P=0.40). As examples, comparison of the
chromosome banding patterns of direct marrows
and CFUs from 5 patients with AML and one
patient with Ph' positive CML are described. One
AML patient was studied twice over a 6-month
period. Clinical and cytogenetic assessments of each
of these patients are presented in Tables I and II.
Cytogenetic analysis of patients presenting with
an abnormal karyotype revealed the presence of
identical clonal chromosomal abnormalities in
direct harvests and CFUs (Table 2, Figures 1-3).
However, karyotypically normal mitoses (with or
without E-rosette depletion prior to culture) were
also observed in cultures from all 5 AML patients
(Table II). We have found no consistent change in
the ratio of normal:abnormal cells in direct vs.CYTOGENETICS OF LEUKAEMIC COLONIES 105
Table I Clinical features of six patients and colony growth characteristics
Case Colony data
Marrow Average , Days
Disease or E-RFC coloniesl of Labelling
No. Sex Age Diagnosis status blood performed 105 cells culturet index
1 F 74 AML 1st Relapse Blood No 380 10 8%
2 M 19 AML 3rd Relapse Marrow No ND* 10 19%
3a F 21 AML 1st Relapse Marrow No 160 7 4%
3b - -- --- 2nd Relapse Marrow No 100 6 ND
4 M 11 AML Relapse Marrow Yes ND 6 ND
5 M 72 AML 1st Relapse Blood Yes 337 3 ND
6 F 65 CML Blastic Marrow Yes 1,050 7 ND
crisis
*ND=Not Determined.
tDay ofculture ofcytogenetic analysis.
Table II Summary ofcytogenetic data from six patients
Percentage of
Total banded cells with
cells abnormal
Case analyzed Abnormal karyotype
no. (culture) karyotype (culture)
1 15
(25)
2 23 45,XY,-14t 60
(50) (46)
3a 15 45,X,+20,-21,t(8; 16)(q22q24) 33.3
(12) (91.6)
3b 20 45,X,+20,-21,t(8; 16)(q22q24) 15.0
(33) (51.5)
4 25 45,XY,-7 94.1
(46) (45.6)
5 25 46,XY,- 12,+t(1; 12)(q21p13) 56.0
(25) (91.4)
6 20 46,XX,t(9;22)(q34q1 1) 100
(29) (100)
tThe only clonal abnormality observed in this patient was -14.
However, random chromosome loss+gain, and substantial chromosome
breakage was also observed.
cultured cells. Both increased (cases 3a, 3b, 5) and
decreased (cases 2, 4) percentages of abnormal cells
were observed in cultured samples. Finally, we have
been unable to recognize karyotypically unique
clonal populations in cultured cells which were not
found in our direct preparations.
One major advantage provided by the colony
assay was the acquisition of a large number of
mitoses suitable for ch,romosome-banding analysis.
With one exception (case 3), chromosome-banding
patterns of cultured cells were superior to direct
preparations from our laboratory. For example, an
unusual translocation was observed in direct and
colony forming cells from case 5. G-banding of
direct chromosones revealed a 46,XY karyotype
with extra material translocated onto the short arm
ofchromosome 12, G-, and C-banding analysis from
CFUs provided specific information on the donor106 J.M. TRENT, J.R. DAVIS & B.G.M. DURIE
Figure 1 Representative G-banded metaphase from LCFUs of case 5. Approximately 90% of all mitoses
evidenced a single clonal karyotypic abnormality; the translocation of chromosomes 1 and 12 [t(1; 12)
(1 qter-. 1q21:: 12p13 12qter)]. Arrow indicates the extra copy of chromosome 1q21-.qter translocated onto
the short arm (p13) ofchromosome 12.
chromosome involved, and breakpoints of the
translocation: t(1; 12)(1qter-+lq21.:12pl3-12qter)
(Figures 1 and 2).
Characterization of AML colony-forming cells
was also derived from examining the relationship
between growth in methylcellulose, with LI and/or
karyotype. Twenty-three patients were evaluated for
LI and subsequently for colony growth. A highly
significant correlation existed between a high LI
((>5%) and leukaemic colony formation (P=0.018)
(Table III). Similarly, when the karyotype of direct
marrows was correlated for growth of leukemic
CFUs, a high correlation existed between the
presence of any karyotypically abnormal clone and
colony growth (P=0.010) (Table III). When the LI
and karyotype for samples with or without
leukaemic colonies were cross-correlated, no
significant difference was observed (P=0.80; 0.20,
respectively). However, this apparent lack of
correlation is explained when leukaemic colony
growth and LI (%) were compared from
chromosomally normal and abnormal cases. A
highly significant correlation existed between
growth and high LI for chromosomally abnormal
samples (P=0.018), while chromosomally normal
samples did not demonstrate a significant
correlation (P=0.28) (Table III).
Because of the possibility of significant differences
between bone marrow and blood CFUs from the
same patient, results from marrow and peripheral
blood CFUs were compared. In 4 patients,
cytogenetics and LI could be compared from both
blood and marrow samples. Karyotype (normal or
abnormal) and LI did not differ between sample
sites in any of these patients. One additional patient
had CFUs from the peripheral blood only and
therefore could not be compared. The proportion of
cases studied for karyotype or LI versus growth in
this assay was similar with or without samples
derived from peripheral blood.Figure 2 Representative C-banded metaphase from LCFUs of case 5. Further confirmation of the
involvement of chromosome lq is revealed by the presence of a large block of constitutive heterochromatin
(arrow) on the translocation chromosome.
Figure 3 G-banded metaphase from LCFUs of a patient with CML (case 6). All cells evidenced the Ph'
translocation between chromosomes 9 and 22 [t(q;22)(q34qll)]. The Ph' chromosome was the only clonal
change noted in both direct and cultured cells from this patient.108 J.M. TRENT, J.R. DAVIS & B.G.M. DURIE
Table III Interrelationship between leukaemic colony growth, direct karyotype, and tritiated
thymidine labelling index
Leukaemic
colony Labelling index (LI)t
growth Direct karyotypet (28pts; 31 studies)
(35pts; (23 pts; 49 studies) Normal karyotype Abnormal karyotype§
49 studies) Normal Abnormal LI-5% .5% LI- <5% >5%
Growth
No. studies 32/49 13/27 19/22 1/5 7/11 1/4 11/11
Percent (65%) (48%) (86%) (20%) (64%) (25%) (100%)
*The Fisher exact test and log-linear model methods were used to statistically compare the
indicated percentages.
tGrowth more likely with abnormal karyotype: p-=0.0I*
$Growth more likely with labelling index (. 5%): p=0.018.
§Growth most likely with both abnormal karyotype and high labelling index (>5%): p=0.018.
Discussion
The success rate in our laboratory of obtaining
analyzable mitoses from leukemic CFUs was similar
to that observed in our laboratory for direct
harvesting techniques. However, the requirement of
greatly increased sample preparation, coupled
with the time-consuming nature of cytogenetic
analysis, would appear to make utilization of this
colony assay for routine cytogenetic analysis too
laborious. Also, in contrast to recent reports
utilizing liquid culture (Knuutila et al., 1981), we
have been unable to recognize clonal
subpopulations in CML or AML unique to or with
increased frequency in colony-forming cells. Thus,
although the mitotic index of samples was often
increased from CFUs, identification of clonal
subpopulations was not increased. However, the
colony assay was very useful in providing large
numbers of mitotic cells suitable for detailed
chromosome banding analysis.
Cytogenetic examination of CML in blast crisis
(case 6) revealed only the presence of Ph' positive
cells (Figure 3). With one exception, (Sonoda et al.,
1980), these results are similar to previous reports of
CFUs from patients with CML (Chervenick et al.,
1971; Moore & Metcalf, 1973). Of perhaps more
interest was the consistent finding in AML patients
of karyotypically "normal" cells from cultures also
displaying colonies with an abnormal karyotype
(Table II, cases 2-5). Although we cannot exclude
the possibility of non-leukaemic CFUs growing in
this system, it is possible that these karyotypically
"normal" mitoses may, in fact, have been of
leukaemic origin and harbor subtle chromosomal
rearrangements unrecognized with current
techniques. Utilizing prometaphase chromosomes,
Yunis et al. (1981) has recently suggested that 100%
of acute non-lymphocytic leukaemia patients
display a cytogenetic abnormality. We are currently
adapting this methodology to colony cells to
determine whether an increased percentage of CFUs
with chromosomal abnormalities can be identified.
Additionally, we are beginning cytogenetic analysis
of single colonies which may provide further
information on the nature of CFU growth in this
assay.
Of major interest is our finding in AML patients
that karyotypically abnormal and/or high LI had
the highest percentage of growth in this blast cell
assay (Table III). These results support previous
findings from this laboratory on multiple myeloma
(Durie et al., in press), suggesting that the
clonogenic fraction is largely derived from cycling
marrow cells. These results may also explain the
relationship of normal to leukaemic cell growth in
agar culture observed in other assays (Verma et al.,
1979; Spitzer et al., 1979). Verma et al. (1979)
suggested that PHA-stimulated patients with only
normal CFU-C growth (therefore negative for
leukaemic growth) in agar culture display a
prognostic advantage over patients with a high
fraction of leukaemic colonies. Although we have
not yet directly correlated our results on colony
formation and survival, it is well known that the
presence of karyotypically abnormal clones
(Shiraishi et al., 1982) or high labelling index (Durie,
1982) are indicators of poor patient prognosis. It is
possible that our low LI-karyotypically normal
population is similar to the category I-A (good
prognosis) patients reported by Spitzer et al. (1979).
We feel that the cytogenetic and cytokinetic
evidence presented in this report provides strong
support for the leukaemic nature of CFUs grown in
the clonal assay of Buick et al. (1977). This assay
may provide a valuable means of providing a large
number of leukaemic metaphases for detailed
cytogenetic analysis.CYTOGENETICS OF LEUKAEMIC COLONIES 109
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